[go: up one dir, main page]

AR122079A1 - Composiciones y métodos para tratar la perdida auditiva asociada a kcnq4 - Google Patents

Composiciones y métodos para tratar la perdida auditiva asociada a kcnq4

Info

Publication number
AR122079A1
AR122079A1 ARP210101314A ARP210101314A AR122079A1 AR 122079 A1 AR122079 A1 AR 122079A1 AR P210101314 A ARP210101314 A AR P210101314A AR P210101314 A ARP210101314 A AR P210101314A AR 122079 A1 AR122079 A1 AR 122079A1
Authority
AR
Argentina
Prior art keywords
kcnq4
compositions
treating
methods
hearing loss
Prior art date
Application number
ARP210101314A
Other languages
English (en)
Inventor
Emmanuel John Simons
Robert Ng
Linda B Couto
Gregory Scott Robinson
Katherine D Gribble
Original Assignee
Akouos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akouos Inc filed Critical Akouos Inc
Publication of AR122079A1 publication Critical patent/AR122079A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a tecnologías que comprenden un polinucleótido capaz de expresar y/o inhibir un producto génico de KCNQ4.
ARP210101314A 2020-05-13 2021-05-12 Composiciones y métodos para tratar la perdida auditiva asociada a kcnq4 AR122079A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063024488P 2020-05-13 2020-05-13

Publications (1)

Publication Number Publication Date
AR122079A1 true AR122079A1 (es) 2022-08-10

Family

ID=76584537

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210101314A AR122079A1 (es) 2020-05-13 2021-05-12 Composiciones y métodos para tratar la perdida auditiva asociada a kcnq4

Country Status (5)

Country Link
US (1) US20230212606A1 (es)
EP (1) EP4165194A2 (es)
AR (1) AR122079A1 (es)
TW (1) TW202208406A (es)
WO (1) WO2021231538A2 (es)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584341D1 (de) 1984-08-24 1991-11-14 Upjohn Co Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US6001650A (en) 1995-08-03 1999-12-14 Avigen, Inc. High-efficiency wild-type-free AAV helper functions
EP0931158A1 (en) 1996-09-06 1999-07-28 The Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
EP2332573A1 (en) 2001-05-31 2011-06-15 Novartis Vaccines and Diagnostics, Inc. Chimeric alphavirus replicon particles
WO2003023026A1 (en) 2001-09-06 2003-03-20 Alphavax, Inc. Alphavirus replicon vector systems
NZ618298A (en) 2001-11-13 2015-04-24 Univ Pennsylvania A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
PT2359869T (pt) 2001-12-17 2019-04-16 Univ Pennsylvania Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
EP2292780B1 (en) 2003-09-30 2017-08-23 The Trustees Of The University Of Pennsylvania Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
US7557197B2 (en) 2004-01-28 2009-07-07 Oregon Health & Science University Human soluble neuropilin-1 primary polyadenylation signal and uses thereof
US20060040354A1 (en) 2004-07-20 2006-02-23 O'keefe Theresa L Novel polyadenylation signal for use in expression vectors
EP2359865B1 (en) 2005-04-07 2013-10-02 The Trustees of The University of Pennsylvania Method of increasing the function of an AAV vector
EP1712641A1 (en) * 2005-04-14 2006-10-18 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Use of novel HNF4a target genes and their gene products
EP2007795B1 (en) 2006-03-30 2016-11-16 The Board Of Trustees Of The Leland Stanford Junior University Aav capsid proteins
WO2011075838A1 (en) * 2009-12-21 2011-06-30 Audigen Inc. Method of treating or preventing hearing loss
JP2015527296A (ja) 2012-03-26 2015-09-17 アメリカ合衆国 哺乳動物細胞へのパッケージングされたｒｎａの新規の送達
KR102794870B1 (ko) * 2015-12-11 2025-04-10 매사추세츠 아이 앤드 이어 인퍼머리 핵산을 와우 및 전정 세포에 전달하기 위한 물질 및 방법
CN112423791A (zh) * 2018-03-05 2021-02-26 儿童医疗中心有限公司 将核酸递送至耳蜗和前庭细胞的组合物和方法

Also Published As

Publication number Publication date
WO2021231538A3 (en) 2022-01-13
EP4165194A2 (en) 2023-04-19
US20230212606A1 (en) 2023-07-06
TW202208406A (zh) 2022-03-01
WO2021231538A2 (en) 2021-11-18

Similar Documents

Publication Publication Date Title
CL2021002326A1 (es) Composiciones de arni contra el angiotensinógeno (agt) y métodos para su uso (divisional de solicitud n° 202002865)
PH12022551013A1 (en) Pyridazinones as parp7 inhibitors
MX2021009886A (es) Enzimas con dominios ruvc.
TN2017000125A1 (en) Compositions and methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
MX2018010427A (es) Formas solidas de un inhibidor de tienopirimidindiona acetil coa carboxilasa y metodos para su produccion.
NZ742742A (en) Compositions and methods for inhibiting arginase activity
AU2016261707A8 (en) Use of cannabis to treat fibromyalgia, methods and compositions thereof
MX2018016057A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
MX2022008775A (es) Metodo para el tratamiento de la epilepsia.
CL2021000650A1 (es) Moduladores de la expresión de pnpla3
MX389449B (es) Composiciones de inh-c1 y métodos para la prevención y el tratamiento de trastornos asociados con la deficiencia del inhibidor de c1 esterasa.
NI202000085A (es) Moduladores de la expresión de apol1
CL2021001488A1 (es) Transposasa de piggybac mutada
WO2020021477A3 (en) Compositions and methods for treating the eye
WO2020021480A3 (en) Compositions and methods for treating the eye
BR112016025333A2 (pt) agente, produto e uso
MX2020009147A (es) Moduladores de la expresion de irf4.
SA522431538B1 (ar) طُرق وتركيبات لعلاج تساقط الشعر
MX2020012990A (es) Formulaciones de tegavivint y compuestos relacionados.
DOP2024000054A (es) Composiciones y métodos para el tratamiento de la pérdida de audición asociada a kcnq4
EP3801620A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PANCREATITIS
CO2021007006A2 (es) Moduladores de la expresión de irf5
AR122079A1 (es) Composiciones y métodos para tratar la perdida auditiva asociada a kcnq4
EP4430216C0 (en) HOT BRICKET IRON PRODUCTION APPARATUS
MX2018007468A (es) Composiciones de colageno 7 y metodos para usar las mismas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal